As a new-type foreign trade service provider driven by dual pillars of technology commercialization and export services, HiSiaddi has built a "1+2+3+4=1" service system and can supply original raw materials from multiple well-known NAD brands.
Adopting an operation model of "1+1>2", HiSiaddi focuses on integrated development of technology transfer and export business, and consistently tracks the global NAD market from both R&D and commercial perspectives. Today, we will conduct a professional analysis of new shifts and trends across the global NAD market.
If you need more comprehensive and valuable insights into the NAD market, please contact HiSiaddi customer service.
Core Change: Global regulation is transitioning from vague and lenient to precise and standardized. Countries worldwide are simultaneously tightening standards for raw material qualifications, purity specifications and labeling claims, making compliance a rigid threshold for market access.
· EU: In Q2 2025, NMN and NR were officially incorporated into the novel food ingredient catalog. Mandatory requirements include raw material purity ≥99.5%, heavy metals (lead/arsenic) ≤1ppm, zero microbial detection. Medical treatment claims are prohibited; only functional labels such as "metabolic support" and "anti-aging aid" are permitted.
· US: The FDA has strengthened GMP audits for dietary supplements. In 2025, 12 batches of non-compliant NAD⁺ raw materials with insufficient purity and impurity adulteration were recalled. Suppliers are required to provide full COA test reports (covering HPLC purity, solvent residues, microorganisms) and full production traceability records.
· China: In March 2025, NMN was included in the Draft Catalogue of Health Food Raw Materials, establishing grading standards: pharmaceutical grade (≥99.9%) and food grade (98%–99.5%). Export raw materials must be accompanied by customs filing credentials and third-party authoritative test reports.
· Key Impacts: Gray supply channels offering low-price unqualified raw materials have been eliminated. Compliant raw materials carry a 15%–20% premium. Uncertified buyers face direct risks of customs detention and product removal from shelves.
Core Change: Synthetic technology has evolved from traditional chemical synthesis to bio-enzymatic fermentation. Raw materials are segmented into pharmaceutical grade, food grade and cosmetic grade. Demand for high-purity (≥99.9%) and high-bioavailability (liposomal/sustained-release) products has surged, while low-end homogeneous products are locked in fierce price wars.
· Technological Upgrades: Leading suppliers (e.g., China’s Biotai) adopt enzymatic catalytic synthesis, delivering stable NMN purity of 99.92% with impurity content below 0.05%. Compared with traditional chemical synthesis (98%–99% purity), bioavailability rises by 40% with no chemical solvent residues, complying with EU Clean Label standards.
· Product Segmentation:
o Pharmaceutical Grade (≥99.9%): For injections and clinical research; global demand surged 58% year-on-year in 2025, primarily supplied to European and American pharmaceutical companies and high-end anti-aging clinics.
o Food Grade (98%–99.5%): For dietary supplements and functional foods, accounting for 68% of market share, yet plagued by intense price competition with average prices down 12% year-on-year in 2025.
o Cosmetic Grade (95%–98%): For anti-aging skincare essences and creams, with demand growing at 35% and marketed for transdermal absorption and antioxidant effects.
· Key Impacts: Profit margins for low-end raw materials (<98% purity) have shrunk to below 5%, while high-purity, high-bioavailability products maintain gross margins of 30%–50%. Technical barriers have become core competitiveness.
Core Change: 85% of global NAD⁺ raw material production capacity is concentrated in China (main production zones: Jiangsu, Zhejiang, Shaanxi), with India and the US accounting for only 10% and 5% respectively. Supply chains have shifted from scattered global sourcing to centralized bulk procurement from core Chinese suppliers paired with small-batch flexible customization. Delivery cycles have shortened from 45 days to 15–20 days.
· China’s Supply Advantages: Ample production capacity (2025 export volume hit 87.4 tons, up 41.2% YoY), mature technology and controllable costs. Pharmaceutical-grade NMN raw materials are 30%–40% cheaper than European and American equivalents.
· Transformed Procurement Modes:
o Top Brands (e.g., Tru Niagen): Sign annual framework agreements with leading Chinese suppliers to lock capacity and cut costs via bulk centralized procurement.
o Small & Medium Brands: Abandon scattered multi-supplier sourcing and switch to 1–2 compliant suppliers for small-batch customization (minimum order quantity as low as 5kg), matching new product testing and flexible inventory demands.
· Key Impacts: Non-Chinese suppliers feature higher premiums, slower delivery and weaker compliance. Overseas buyers failing to secure partnerships with compliant Chinese suppliers face capacity shortages and price volatility risks.
Core Change: NAD⁺ applications have expanded beyond standalone dietary supplements into four major segments: anti-aging medical care, metabolic health management, high-end cosmetics and functional foods. Downstream buyers have diversified, with demand evolving from simple raw material purchasing to integrated procurement of "raw materials + formulations + technical services".
· Dietary Supplements (68% market share): The primary segment, with robust demand among high-net-worth consumers aged 30–45, marketed for anti-aging, energy boost and sleep improvement.
· Anti-Aging Medical Care (15% market share): Purchased by high-end clinics and private hospitals for intravenous infusions and combined stem cell therapies, with demand growing at 50%.
· High-End Cosmetics (10% market share): NAD⁺ precursors added to anti-aging essences, creams and masks for DNA repair, antioxidant and skin firming effects; global demand for cosmetic-grade NAD⁺ raw materials rose 42% YoY in 2025.
· Functional Foods (7% market share): Added to energy drinks, meal replacement powders and probiotics to boost metabolism and immunity.
· Key Impacts: Margins shrink for pure raw material resale. Buyers capable of formulation R&D and technical support can boost product premiums via integrated "raw material + custom formulation" offerings to strengthen competitiveness.
1. Severe Compliance Risks: Tightening European and American regulations mean unqualified raw materials risk customs detention and product removal. In 2025, 23 small and medium brands exited the market due to non-compliant raw materials.
2. Intense Price Competition: Homogenized food-grade NAD⁺ raw materials pushed average prices down 12% YoY in 2025, compressing gross margins to 10%–15% and narrowing survival space for small brands.
3. Difficulty Achieving Product Differentiation: Most brands only perform simple raw material blending with no core technical barriers, leading to low consumer loyalty and vulnerability to low-price competitors.
4. Unstable Supply Chains: Heavy reliance on Chinese suppliers creates risks of stockouts and delivery delays amid environmental production restrictions and logistics disruptions.
1. Blue Ocean of High-Value-Added Products: Liposomal NMN and sustained-release NR deliver gross margins of 30%–40% with market penetration below 10%, creating low-competition opportunities.
2. Surging Segmented Demand: Customized formulations targeting female anti-aging, male energy enhancement and elderly metabolic regulation see growth exceeding 40% with substantial premium potential.
3. Dividend of Channel Penetration: Cross-border e-commerce and offline health management chains account for 34.7% of purchases. Small brands can avoid head-on competition with major players by focusing on segmented channels.
4. Dividend of China’s Supply Chain: Partnering with compliant Chinese suppliers unlocks cost advantages (30%–40% lower prices), faster delivery (15–20 days) and technical support to reduce procurement expenses.
1. Stringent Raw Material Purity Requirements: Pharmaceutical-grade NAD⁺ (≥99.9%) meeting pharmacopoeia standards for impurities and solvent residues is mandatory, yet qualified suppliers remain scarce and procurement costs high.
2. Heavy Dependence on Technical Support: Institutions require suppliers to provide clinical application guidance, formulation optimization and testing support; ordinary raw material suppliers cannot meet these needs, leading to gaps between qualified raw materials and unsatisfactory therapeutic effects.
3. Rigorous Qualification Audits: Medical institutions purchasing in Europe and the US demand GMP certifications, DMF files and clinical research data from suppliers, with audit cycles stretching 3–6 months and high entry barriers.
4. Difficulty Building Customer Trust: Limited consumer awareness of NAD⁺ anti-aging efficacy forces institutions to back claims with authoritative clinical data and case studies, raising marketing difficulties.
1. High Unit Price Dividend: NAD⁺ intravenous infusion and anti-aging packages carry unit prices of USD 5,000–20,000 with gross margins of 60%–80%, vastly outperforming standard aesthetic treatments.
2. Differentiating Competitive Barriers: Exclusive custom high-purity compound formulations (NMN+NR+CoQ10) paired with supplier technical support create one-of-a-kind core advantages.
3. Precision Medicine Trend: Combined NAD⁺, stem cell and genetic testing therapies are emerging as mainstream high-end anti-aging solutions. Institutions adopting an integrated "raw material + technology + service" model can lock in high-net-worth clients.
4. Dividend of Premium Chinese Suppliers: Leading Chinese suppliers (e.g., Biotai) provide pharmaceutical-grade raw materials, clinical technical support and full qualification documentation at prices 40% lower than Western alternatives, cutting operational costs for institutions.
1. High Raw Material Adaptation Standards: Cosmetics require transdermal liposomal NAD⁺, while functional foods demand heat-resistant, easily soluble raw materials. Standard raw materials fail to fit these requirements, driving up customization costs.
2. Restrictive Labeling Claims: Cosmetics may only label "antioxidation, skin repair", and functional foods "metabolism boost, immunity enhancement"; medical therapeutic claims are banned, limiting marketing flexibility.
3. Weak Formulation R&D Capacity: Most manufacturers lack dedicated NAD⁺ formulation teams, unable to independently develop differentiated products and falling into homogenized competition.
4. High Small-Batch Procurement Premiums: Cosmetic and functional food orders typically range from 5–50kg, while traditional suppliers enforce high minimum order quantities (100kg), adding a 20%–30% premium to small-lot purchases.
1. Blue Ocean Emerging Segments: Penetration of NAD⁺ cosmetics and functional foods stands below 5%, with a compound annual growth rate exceeding 35% from 2025–2030, offering low competition and large premium room.
2. Flexible Customization Dividend: Select Chinese suppliers offer small-batch customization with MOQs as low as 5kg, supporting small-scale trial production and new product testing for cosmetics and functional foods.
3. Cross-Sector Integration Advantages: Blending NAD⁺ with hyaluronic acid/collagen (cosmetics) or probiotics/dietary fiber (functional foods) creates differentiated products positioned as "anti-aging + moisturizing" or "metabolism + gut health", appealing to young consumers.
4. Compliance Dividend: Cosmetics and functional foods face lower regulatory thresholds than dietary supplements and medical products. Early deployment of fully compliant products enables rapid capture of emerging market share.
1. Supplier Screening Hard Standards (all mandatory):
o Qualifications: Possess GMP certification, ISO22000 food safety certification and customs export filing credentials; able to provide complete COA reports and full production traceability records.
o Purity: Select food grade (≥99%) for dietary supplements, pharmaceutical/cosmetic grade (≥99.9%) for medical and aesthetic applications; reject low-price raw materials below 98% purity.
o Technology: Deploy bio-enzymatic synthesis technology and formulation R&D capabilities, capable of custom development and technical after-sales support.
2. Qualification Audit Workflow: Verify supplier business licenses, certification documents and test reports prior to procurement; commission third-party authoritative bodies (SGS, Intertek etc.) to conduct re-inspection upon raw material arrival to guarantee compliance.
3. Reserve Compliance Documentation: Pre-prepare COA reports, GMP certificates, certificates of origin and customs filing files to clear European and American customs and regulatory audits without product detention.
1. Segment Prioritization (Abandon low-end low-margin lines, focus on high gross margin products):
o Dietary Supplement Brands: Prioritize liposomal NMN, sustained-release NR and compound formulations (NMN + resveratrol + vitamin C) to lift gross margins to 30%–40%.
o Medical Aesthetic Clinics: Launch pharmaceutical-grade NAD⁺ infusions and high-concentration anti-aging essences (NMN + hyaluronic acid) targeting high-net-worth clients.
o Cosmetic & Functional Food Manufacturers: Develop transdermal liposomal NAD⁺ (cosmetics) and heat-resistant NMN granules (functional foods) tailored to scenario-specific requirements.
2. Formulation R&D (Dual model of independent + collaborative development):
o Small & Medium Buyers: Co-develop custom formulations with suppliers, leveraging supplier technical expertise to create differentiated products at low R&D cost.
o Major Buyers: Establish dedicated formulation R&D teams to develop exclusive patented formulations and build technical moats.
3. Boost Bioavailability: Prioritize raw materials processed with liposomal encapsulation, nanospheres or sustained-release technology to lift absorption rates by 300%–500%, enhance consumer experience and drive repeat purchases.
1. Secure Long-Term Core Supplier Partnerships (1–2 primary vendors):
o Sign 1–3 year annual framework agreements with leading compliant Chinese suppliers to lock production capacity, stabilize pricing and guarantee 15–20 day delivery cycles.
o Negotiate small-batch customization clauses (MOQ ≥5kg) to support new product testing and flexible inventory management, reducing overstock risks.
2. Inventory Optimization (Blend zero-inventory and safety stock strategies):
o Standard SKUs: Adopt on-demand procurement with orders placed 15 days in advance for fast supplier delivery, achieving zero inventory and cutting capital occupation.
o Hot-Selling SKUs: Maintain 1–2 months of safety stock to offset sudden order surges and logistics disruptions and avoid stockouts.
3. Logistics Optimization: Choose China-Europe Railway Express or international couriers (DHL/FEDEX) to shorten delivery cycles to 15–20 days and mitigate ocean freight delay risks; purchase cargo insurance to cover transport damage and loss.
1. Precise Demographic Positioning:
o Dietary Supplements: Target high-net-worth office workers aged 30–45, highlighting anti-aging, energy boost and sleep improvement benefits.
o Medical Aesthetic Clinics: Target high-end anti-aging consumers aged 50+ and celebrities, emphasizing cellular anti-aging and age reversal repair.
o Cosmetics: Target women aged 25–40, positioning products for antioxidant, skin repair and anti-wrinkle firming effects.
2. Reinforce Trust Endorsements to Resolve Consumer Perception Barriers:
o Compliance Endorsement: Mark raw material purity, test report serial numbers and compliance certifications on product packaging and marketing pages for full transparency to build trust.
o Efficacy Endorsement: Provide authoritative clinical research data, authentic customer testimonials and before/after comparison imagery to validate anti-aging and metabolic improvement effects.
o Safety Endorsement: Highlight zero chemical solvent residues, low heavy metal content and minimal side effects, aligned with European and American safety standards to eliminate consumer concerns.
3. Targeted Channel Layout:
o Online: Deploy cross-border e-commerce platforms (Amazon, independent websites), health KOL livestreams and professional nutrition portals to accurately reach target audiences.
o Offline: Place dietary supplements in premium supermarkets and health management chains; medical aesthetic clinics focus on high-end commercial districts and private hospitals; cosmetics stock at luxury beauty collection stores and spas.
The NAD⁺ market is undergoing a pivotal transformation toward full compliance, high-end positioning and differentiated competition. Low-end homogeneous products are rapidly being phased out, while compliance, high purity, high bioavailability and proprietary differentiated formulations form the core competitive edge. For overseas B2B buyers, locking in compliant core Chinese suppliers, focusing on high-value-added product lines, building flexible supply chains and reinforcing multi-layered trust endorsements represent the only viable path to mitigate risks and capture market share.
For more authentic, objective introductions to multiple leading Chinese NAD brands, contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
